Back to EPRX
RAYMOND JAMES FINANCIAL INC → EPRX
RAYMOND JAMES FINANCIAL INC EPRX Position History
Eupraxia Pharmaceuticals Inc. • Healthcare
Quarters held
10
Latest value
$429K
Q3 2026
Peak value
$429K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1K |
| Q3 2025 | $196K |
| Q4 2025 | $2K |
| Q4 2025 | $398K |
| Q1 2026 | $74K |
| Q1 2026 | $292K |
| Q2 2026 | $81K |
| Q2 2026 | $273K |
| Q3 2026 | $49K |
| Q3 2026 | $429K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $429K | 47.1K | — | — |
| Q3 2026 | $49K | 5.3K | — | — |
| Q2 2026 | $273K | 41.3K | — | — |
| Q2 2026 | $81K | 12.2K | — | — |
| Q1 2026 | $292K | 40.3K | — | — |
| Q1 2026 | $74K | 10.2K | — | — |
| Q4 2025 | $398K | 52.8K | — | — |
| Q4 2025 | $2K | 220 | — | — |
| Q3 2025 | $196K | 33.2K | — | — |
| Q3 2025 | $1K | 220 | — | — |